Cargando…
Pregnancy and Progression of Cardiomyopathy in Women With LMNA Genotype‐Positive
BACKGROUND: We aimed to assess the association between number of pregnancies and long‐term progression of cardiac dysfunction, arrhythmias, and event‐free survival in women with pathogenic or likely pathogenic variants of gene encoding for Lamin A/C proteins ( LMNA+). METHODS AND RESULTS: We retrosp...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238471/ https://www.ncbi.nlm.nih.gov/pubmed/35434999 http://dx.doi.org/10.1161/JAHA.121.024960 |
_version_ | 1784737057249165312 |
---|---|
author | Castrini, Anna I. Skjølsvik, Eystein Estensen, Mette E. Almaas, Vibeke M. Skulstad, Helge Lyseggen, Erik Edvardsen, Thor Lie, Øyvind H. Picard, Kermshlise C. I. Lakdawala, Neal K. Haugaa, Kristina H. |
author_facet | Castrini, Anna I. Skjølsvik, Eystein Estensen, Mette E. Almaas, Vibeke M. Skulstad, Helge Lyseggen, Erik Edvardsen, Thor Lie, Øyvind H. Picard, Kermshlise C. I. Lakdawala, Neal K. Haugaa, Kristina H. |
author_sort | Castrini, Anna I. |
collection | PubMed |
description | BACKGROUND: We aimed to assess the association between number of pregnancies and long‐term progression of cardiac dysfunction, arrhythmias, and event‐free survival in women with pathogenic or likely pathogenic variants of gene encoding for Lamin A/C proteins ( LMNA+). METHODS AND RESULTS: We retrospectively included consecutive women with LMNA+ and recorded pregnancy data. We collected echocardiographic data, occurrence of atrial fibrillation, atrioventricular block, sustained ventricular arrhythmias, and implantation of cardiac electronic devices (implantable cardioverter defibrillator/cardiac resynchronization therapy defibrillator). We analyzed retrospectively complications during pregnancy and the peripartum period. We included 89 women with LMNA+ (28% probands, age 41±16 years), of which 60 had experienced pregnancy. Follow‐up time was 5 [interquartile range, 3–9] years. We analyzed 452 repeated echocardiographic examinations. Number of pregnancies was not associated with increased long‐term risk of atrial fibrillation, atrioventricular block, sustained ventricular arrhythmias, or implantable cardioverter defibrillator/cardiac resynchronization therapy defibrillator implantation. Women with previous pregnancy and nulliparous women had a similar annual deterioration of left ventricular ejection fraction (−0.5/year versus −0.3/year, P=0.37) and similar increase of left ventricular end‐diastolic diameter (0.1/year versus 0.2/year, P=0.09). Number of pregnancies did not decrease survival free from death, left ventricular assist device, or need for cardiac transplantation. Arrhythmias occurred during 9% of pregnancies. No increase in maternal and fetal complications was observed. CONCLUSIONS: In our cohort of women with LMNA+, pregnancy did not seem associated with long‐term adverse disease progression or event‐free survival. Likewise, women with LMNA+ generally well‐tolerated pregnancy, with a small proportion of patients experiencing arrhythmias. |
format | Online Article Text |
id | pubmed-9238471 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92384712022-06-30 Pregnancy and Progression of Cardiomyopathy in Women With LMNA Genotype‐Positive Castrini, Anna I. Skjølsvik, Eystein Estensen, Mette E. Almaas, Vibeke M. Skulstad, Helge Lyseggen, Erik Edvardsen, Thor Lie, Øyvind H. Picard, Kermshlise C. I. Lakdawala, Neal K. Haugaa, Kristina H. J Am Heart Assoc Original Research BACKGROUND: We aimed to assess the association between number of pregnancies and long‐term progression of cardiac dysfunction, arrhythmias, and event‐free survival in women with pathogenic or likely pathogenic variants of gene encoding for Lamin A/C proteins ( LMNA+). METHODS AND RESULTS: We retrospectively included consecutive women with LMNA+ and recorded pregnancy data. We collected echocardiographic data, occurrence of atrial fibrillation, atrioventricular block, sustained ventricular arrhythmias, and implantation of cardiac electronic devices (implantable cardioverter defibrillator/cardiac resynchronization therapy defibrillator). We analyzed retrospectively complications during pregnancy and the peripartum period. We included 89 women with LMNA+ (28% probands, age 41±16 years), of which 60 had experienced pregnancy. Follow‐up time was 5 [interquartile range, 3–9] years. We analyzed 452 repeated echocardiographic examinations. Number of pregnancies was not associated with increased long‐term risk of atrial fibrillation, atrioventricular block, sustained ventricular arrhythmias, or implantable cardioverter defibrillator/cardiac resynchronization therapy defibrillator implantation. Women with previous pregnancy and nulliparous women had a similar annual deterioration of left ventricular ejection fraction (−0.5/year versus −0.3/year, P=0.37) and similar increase of left ventricular end‐diastolic diameter (0.1/year versus 0.2/year, P=0.09). Number of pregnancies did not decrease survival free from death, left ventricular assist device, or need for cardiac transplantation. Arrhythmias occurred during 9% of pregnancies. No increase in maternal and fetal complications was observed. CONCLUSIONS: In our cohort of women with LMNA+, pregnancy did not seem associated with long‐term adverse disease progression or event‐free survival. Likewise, women with LMNA+ generally well‐tolerated pregnancy, with a small proportion of patients experiencing arrhythmias. John Wiley and Sons Inc. 2022-04-18 /pmc/articles/PMC9238471/ /pubmed/35434999 http://dx.doi.org/10.1161/JAHA.121.024960 Text en © 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Castrini, Anna I. Skjølsvik, Eystein Estensen, Mette E. Almaas, Vibeke M. Skulstad, Helge Lyseggen, Erik Edvardsen, Thor Lie, Øyvind H. Picard, Kermshlise C. I. Lakdawala, Neal K. Haugaa, Kristina H. Pregnancy and Progression of Cardiomyopathy in Women With LMNA Genotype‐Positive |
title | Pregnancy and Progression of Cardiomyopathy in Women With LMNA Genotype‐Positive |
title_full | Pregnancy and Progression of Cardiomyopathy in Women With LMNA Genotype‐Positive |
title_fullStr | Pregnancy and Progression of Cardiomyopathy in Women With LMNA Genotype‐Positive |
title_full_unstemmed | Pregnancy and Progression of Cardiomyopathy in Women With LMNA Genotype‐Positive |
title_short | Pregnancy and Progression of Cardiomyopathy in Women With LMNA Genotype‐Positive |
title_sort | pregnancy and progression of cardiomyopathy in women with lmna genotype‐positive |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238471/ https://www.ncbi.nlm.nih.gov/pubmed/35434999 http://dx.doi.org/10.1161/JAHA.121.024960 |
work_keys_str_mv | AT castriniannai pregnancyandprogressionofcardiomyopathyinwomenwithlmnagenotypepositive AT skjølsvikeystein pregnancyandprogressionofcardiomyopathyinwomenwithlmnagenotypepositive AT estensenmettee pregnancyandprogressionofcardiomyopathyinwomenwithlmnagenotypepositive AT almaasvibekem pregnancyandprogressionofcardiomyopathyinwomenwithlmnagenotypepositive AT skulstadhelge pregnancyandprogressionofcardiomyopathyinwomenwithlmnagenotypepositive AT lyseggenerik pregnancyandprogressionofcardiomyopathyinwomenwithlmnagenotypepositive AT edvardsenthor pregnancyandprogressionofcardiomyopathyinwomenwithlmnagenotypepositive AT lieøyvindh pregnancyandprogressionofcardiomyopathyinwomenwithlmnagenotypepositive AT picardkermshliseci pregnancyandprogressionofcardiomyopathyinwomenwithlmnagenotypepositive AT lakdawalanealk pregnancyandprogressionofcardiomyopathyinwomenwithlmnagenotypepositive AT haugaakristinah pregnancyandprogressionofcardiomyopathyinwomenwithlmnagenotypepositive |